Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle

Andrea Farini, Clementina Sitzia, Letizia Cassinelli, Federica Colleoni, Daniele Parolini, Umberto Giovanella, Simona Maciotta, Augusto Colombo, Mirella Meregalli, Yvan Torrente

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Duchenne muscular dystrophy (DMD) is a progressiveneuromuscular disorder characterized by muscle wasting andpremature death. The defective gene is dystrophin, a structuralprotein, absence of which causes membrane fragility and myofibernecrosis. Several lines of evidence showed that in adult DMD patientsdystrophin is involved in signaling pathways that regulate calciumhomeostasis and differentiation programs. However, secondaryaspects of the disease, such as inflammation and fibrosisdevelopment, might represent a bias in the analysis. Because fetalmuscle is not influenced by gravity and does not suffer frommechanical load and/or inflammation, we investigated 12-week-oldfetal DMD skeletal muscles, highlighting for the first time earlyalterations in signaling pathways mediated by the absence ofdystrophin itself. We found that PLC/IP3/IPR3/Ryr1/Ca2+ signalingis widely active in fetal DMD skeletal muscles and, through thecalcium-dependent PKCα protein, exerts a fundamental regulatoryrole in delaying myogenesis and in myofiber commitment. These dataprovide new insights into the origin of DMD pathology during muscledevelopment.

Original languageEnglish
Pages (from-to)658-669
Number of pages12
JournalDevelopment
Volume143
Issue number4
DOIs
Publication statusPublished - Feb 15 2016

Fingerprint

Inositol 1,4,5-Trisphosphate
Duchenne Muscular Dystrophy
Muscle Development
Muscles
Skeletal Muscle
Inflammation
Dystrophin
Ryanodine Receptor Calcium Release Channel
Gravitation
Muscular Diseases
Pathology
Membranes
Genes
Proteins

Keywords

  • Calcium channels
  • DMD fetus
  • Dystrophin signaling
  • IP3/IP3R pathway
  • Myosin isoforms

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology

Cite this

Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle. / Farini, Andrea; Sitzia, Clementina; Cassinelli, Letizia; Colleoni, Federica; Parolini, Daniele; Giovanella, Umberto; Maciotta, Simona; Colombo, Augusto; Meregalli, Mirella; Torrente, Yvan.

In: Development, Vol. 143, No. 4, 15.02.2016, p. 658-669.

Research output: Contribution to journalArticle

Farini, A, Sitzia, C, Cassinelli, L, Colleoni, F, Parolini, D, Giovanella, U, Maciotta, S, Colombo, A, Meregalli, M & Torrente, Y 2016, 'Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle', Development, vol. 143, no. 4, pp. 658-669. https://doi.org/10.1242/dev.126193
Farini, Andrea ; Sitzia, Clementina ; Cassinelli, Letizia ; Colleoni, Federica ; Parolini, Daniele ; Giovanella, Umberto ; Maciotta, Simona ; Colombo, Augusto ; Meregalli, Mirella ; Torrente, Yvan. / Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle. In: Development. 2016 ; Vol. 143, No. 4. pp. 658-669.
@article{a217bfb0a3154f4a89ebfbd40fb02be0,
title = "Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle",
abstract = "Duchenne muscular dystrophy (DMD) is a progressiveneuromuscular disorder characterized by muscle wasting andpremature death. The defective gene is dystrophin, a structuralprotein, absence of which causes membrane fragility and myofibernecrosis. Several lines of evidence showed that in adult DMD patientsdystrophin is involved in signaling pathways that regulate calciumhomeostasis and differentiation programs. However, secondaryaspects of the disease, such as inflammation and fibrosisdevelopment, might represent a bias in the analysis. Because fetalmuscle is not influenced by gravity and does not suffer frommechanical load and/or inflammation, we investigated 12-week-oldfetal DMD skeletal muscles, highlighting for the first time earlyalterations in signaling pathways mediated by the absence ofdystrophin itself. We found that PLC/IP3/IPR3/Ryr1/Ca2+ signalingis widely active in fetal DMD skeletal muscles and, through thecalcium-dependent PKCα protein, exerts a fundamental regulatoryrole in delaying myogenesis and in myofiber commitment. These dataprovide new insights into the origin of DMD pathology during muscledevelopment.",
keywords = "Calcium channels, DMD fetus, Dystrophin signaling, IP3/IP3R pathway, Myosin isoforms",
author = "Andrea Farini and Clementina Sitzia and Letizia Cassinelli and Federica Colleoni and Daniele Parolini and Umberto Giovanella and Simona Maciotta and Augusto Colombo and Mirella Meregalli and Yvan Torrente",
year = "2016",
month = "2",
day = "15",
doi = "10.1242/dev.126193",
language = "English",
volume = "143",
pages = "658--669",
journal = "Development (Cambridge)",
issn = "0950-1991",
publisher = "Company of Biologists Ltd",
number = "4",

}

TY - JOUR

T1 - Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle

AU - Farini, Andrea

AU - Sitzia, Clementina

AU - Cassinelli, Letizia

AU - Colleoni, Federica

AU - Parolini, Daniele

AU - Giovanella, Umberto

AU - Maciotta, Simona

AU - Colombo, Augusto

AU - Meregalli, Mirella

AU - Torrente, Yvan

PY - 2016/2/15

Y1 - 2016/2/15

N2 - Duchenne muscular dystrophy (DMD) is a progressiveneuromuscular disorder characterized by muscle wasting andpremature death. The defective gene is dystrophin, a structuralprotein, absence of which causes membrane fragility and myofibernecrosis. Several lines of evidence showed that in adult DMD patientsdystrophin is involved in signaling pathways that regulate calciumhomeostasis and differentiation programs. However, secondaryaspects of the disease, such as inflammation and fibrosisdevelopment, might represent a bias in the analysis. Because fetalmuscle is not influenced by gravity and does not suffer frommechanical load and/or inflammation, we investigated 12-week-oldfetal DMD skeletal muscles, highlighting for the first time earlyalterations in signaling pathways mediated by the absence ofdystrophin itself. We found that PLC/IP3/IPR3/Ryr1/Ca2+ signalingis widely active in fetal DMD skeletal muscles and, through thecalcium-dependent PKCα protein, exerts a fundamental regulatoryrole in delaying myogenesis and in myofiber commitment. These dataprovide new insights into the origin of DMD pathology during muscledevelopment.

AB - Duchenne muscular dystrophy (DMD) is a progressiveneuromuscular disorder characterized by muscle wasting andpremature death. The defective gene is dystrophin, a structuralprotein, absence of which causes membrane fragility and myofibernecrosis. Several lines of evidence showed that in adult DMD patientsdystrophin is involved in signaling pathways that regulate calciumhomeostasis and differentiation programs. However, secondaryaspects of the disease, such as inflammation and fibrosisdevelopment, might represent a bias in the analysis. Because fetalmuscle is not influenced by gravity and does not suffer frommechanical load and/or inflammation, we investigated 12-week-oldfetal DMD skeletal muscles, highlighting for the first time earlyalterations in signaling pathways mediated by the absence ofdystrophin itself. We found that PLC/IP3/IPR3/Ryr1/Ca2+ signalingis widely active in fetal DMD skeletal muscles and, through thecalcium-dependent PKCα protein, exerts a fundamental regulatoryrole in delaying myogenesis and in myofiber commitment. These dataprovide new insights into the origin of DMD pathology during muscledevelopment.

KW - Calcium channels

KW - DMD fetus

KW - Dystrophin signaling

KW - IP3/IP3R pathway

KW - Myosin isoforms

UR - http://www.scopus.com/inward/record.url?scp=84958280872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958280872&partnerID=8YFLogxK

U2 - 10.1242/dev.126193

DO - 10.1242/dev.126193

M3 - Article

C2 - 26884398

AN - SCOPUS:84958280872

VL - 143

SP - 658

EP - 669

JO - Development (Cambridge)

JF - Development (Cambridge)

SN - 0950-1991

IS - 4

ER -